[ad_1]
The benefit-risk ratio of the product is acceptable, he said.
After Great Britain, Argentina also approved the corona vaccine from the University of Oxford and the pharmaceutical company Astrazeneca. According to its own information, the pharmaceutical authority Anmat issued an emergency registration for the sale of the prescription drug, limited to one year.
The benefit-risk ratio of the product is acceptable, he said. It was not initially clear when the preparation was expected and how many doses the South American country should receive.
Also on Wednesday, the British pharmaceuticals regulator granted the vaccine from the British-Swedish pharmaceutical company Astrazeneca and emergency approval from the University of Oxford. Studies showed that the drug was less effective than the Biontech and Pfizer vaccine, which has already been approved in some countries, including Argentina. However, it can be stored with much less effort and is significantly cheaper. According to the British Ministry of Health, it also offers protection against Covid 19 disease after the first of two vaccinations.
Russia and Astrazeneca work together
Just on Tuesday, Argentina began to administer the “Sputnik V” vaccine developed by Russian researchers. The vaccine had already been launched in Russia in mid-August and has been used there since the beginning of this month. Last week, Russia and Astrazeneca signed a memorandum for a collaboration on vaccine development.
According to official figures, Argentina, which has around 45 million inhabitants, ranks twelfth in the world with 1.6 million corona infections, just behind Germany, which has almost twice the population. So far, more than 43,000 deaths related to the Covid 19 disease have been registered in Argentina.
(WHAT)
